Chegg Inc Has Record 2020; Looks Stronger in 2021 Chegg Inc (NYSE:CHGG) is a stock I’ve been bullish on for years. Chegg stock was an excellent stock before the coronavirus pandemic, and it should continue to do exceptionally well in the post-pandemic world. That’s because online education isn’t going anywhere. If... Read more
Renewable Energy Group Inc Could Clean Up Under Biden’s Green Plan Green energy was not something you wanted to talk about in the last U.S. administration, but with President Joe Biden in command, it has become a major talking point. Solar, wind, hydrogen, and electric stocks have surged. If... Read more
Field Trip Health just announced the 3rd largest financing by a psychedelics public company: a CAD$82.875 million bought deal. Here’s what it means for investors.
The nation’s state agriculture departments have joined the call for raising the THC limit in hemp from 0.3% to a full 1%. But the National Association of State Departments of Agriculture did not say in its policy statement how states propose making that change. The platform was adopted Thursday... Read more
Ryan Allway March 1st, 2021 Psychedelics Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine”), an emerging biopharma company in the life sciences category committed to the research and development, production, and acceptance of alternative nature-sourced medicine for mainstream use, has completed the world’s first international legal export... Read more
Ryan Allway March 1st, 2021 Psychedelics Novamind Inc. (CSE:NM)(OTC PINK:NVMDF) (“Novamind”), a leading mental health company specialized in psychedelic medicine, today reported its fiscal second quarter results for the three months ended December 31, 2020 (“Fiscal Q2 2021″). The Company’s fiscal year-end is June 30th. All results are reported... Read more
Ryan Allway March 1st, 2021 Psychedelics Newscope Capital Corporation (“Newscope”) (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce today that its common shares are now eligible... Read more
Ryan Allway March 1st, 2021 Psychedelics Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One”) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce readiness to begin initial biosynthetic psilocybin production trials. The Company’s... Read more
